Comparison of four antimicrobial susceptibility testing methods to determine the in vitro activities of piperacillin and piperacillin-tazobactam against clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosaKARLOWSKY, James A; WEAVER, Mellany K; THORNSBERRY, Clyde et al.Journal of clinical microbiology (Print). 2003, Vol 41, Num 7, pp 3339-3343, issn 0095-1137, 5 p.Article

Factors associated with relative rates of antimicrobial resistance among Streptococcus pneumoniae in the United States: Results from the Trust Surveillance Program (1998-2002)KARLOWSKY, James A; THORNSBERRY, Clyde; JONES, Mark E et al.Clinical infectious diseases. 2003, Vol 36, Num 8, pp 963-970, issn 1058-4838, 8 p.Article

Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States, 1998 to 2001KARLOWSKY, James A; DRAGHI, Deborah C; JONES, Mark E et al.Antimicrobial agents and chemotherapy. 2003, Vol 47, Num 5, pp 1681-1688, issn 0066-4804, 8 p.Article

Clinical isolates of Streptococcus pneumoniae with different susceptibilities to ceftriaxone and cefotaximeKARLOWSKY, James A; JONES, Mark E; DRAGHI, Deborah C et al.Antimicrobial agents and chemotherapy. 2003, Vol 47, Num 10, pp 3155-3160, issn 0066-4804, 6 p.Article

Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United StatesKARLOWSKY, James A; KELLY, Laurie J; THORNSBERRY, Clyde et al.Antimicrobial agents and chemotherapy. 2002, Vol 46, Num 8, pp 2540-2545, issn 0066-4804Article

Stable antimicrobial susceptibility rates for clinical isolates of Pseudomonas aeruginosa from the 2001-2003 tracking resistance in the United States today surveillance studiesKARLOWSKY, James A; JONES, Mark E; THORNSBERRY, Clyde et al.Clinical infectious diseases. 2005, Vol 40, pp S89-S98, issn 1058-4838, SUP2Article

Activities of faropenem, an oral β-lactam, against recent U.S. isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalisCRITCHLEY, Ian A; KARLOWSKY, James A; DRAGHI, Deborah C et al.Antimicrobial agents and chemotherapy. 2002, Vol 46, Num 2, pp 550-555, issn 0066-4804Article

In vitro activities of novel nonfluorinated quinolones PGE 9262932 and PGE 9509924 against clinical isolates of Staphylococcus aureus and Streptococcus pneumoniae with defined mutations in DNA gyrase and topoisomerase IVJONES, Mark E; CRITCHLEY, Ian A; KARLOWSKY, James A et al.Antimicrobial agents and chemotherapy. 2002, Vol 46, Num 6, pp 1651-1657, issn 0066-4804Article

In vitro susceptibility of recent clinical isolates of pneumococci to the investigational cephalosporin cefditorenKARLOWSKY, James A; JONES, Mark E; DRAGHI, Deborah C et al.Diagnostic microbiology and infectious disease. 2002, Vol 42, Num 1, pp 59-64, issn 0732-8893Article

The activity of levofloxacin and comparator agents against clinical isolates of Streptococcus pneumoniae collected worldwide during 1999 and 2000JONES, Mark E; BLOSSER-MIDDLETON, Renee S; CRITCHLEY, Ian A et al.Chemotherapy (Basel). 2002, Vol 48, Num 5, pp 232-237, issn 0009-3157, 6 p.Article

Reactor Scale-up for Fluidized Bed Conversion of Ethane to Vinyl ChlorideHICKMAN, Daniel A; JONES, Mark E; JOVANOVIC, Zoran R et al.Industrial & engineering chemistry research. 2010, Vol 49, Num 21, pp 10674-10681, issn 0888-5885, 8 p.Conference Paper

Antibiotic susceptibility of bacteria most commonly isolated from bone related infections: the role of cephalosporins in antimicrobial therapyJONES, Mark E; KARLOWSKY, James A; DRAGHI, Deborah C et al.International journal of antimicrobial agents. 2004, Vol 23, Num 3, pp 240-246, issn 0924-8579, 7 p.Article

Epidemiology and antibiotic susceptibility of bacteria causing skin and soft tissue infections in the USA and Europe: a guide to appropriate antimicrobial therapyJONES, Mark E; KARLOWSKY, James A; DRAGHI, Deborah C et al.International journal of antimicrobial agents. 2003, Vol 22, Num 4, pp 406-419, issn 0924-8579, 14 p.Article

Activity of cefditoren against β-lactamase-positive and -negative Haemophilus influenzae and Moraxella catarrhalisKARLOWSKY, James A; CRITCHLEY, Ian A; DRAGHI, Deborah C et al.Diagnostic microbiology and infectious disease. 2002, Vol 42, Num 1, pp 53-58, issn 0732-8893Article

Antimicrobial surveillance of Haemophilus influenzae in the United States during 2000-2001 leads to detection of clonal dissemination of a β-lactamase-negative and ampicillin-resistant strainKARLOWSKY, James A; CRITCHLEY, Ian A; BLOSSER-MIDDLETON, Renée S et al.Journal of clinical microbiology (Print). 2002, Vol 40, Num 3, pp 1063-1066, issn 0095-1137Article

Determining linezolid's baseline in vitro activity in Canada using gram-positive clinical isolates collected prior to its national releaseKARLOWSKY, James A; KELLY, Laurie J; CRITCHLEY, Ian A et al.Antimicrobial agents and chemotherapy. 2002, Vol 46, Num 6, pp 1989-1992, issn 0066-4804Article

Regional trends in antimicrobial Resistance among clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States: Results from the TRUST surveillance program, 1999-2000THORNSBERRY, Clyde; SAHM, Daniel F; KELLY, Laurie J et al.Clinical infectious diseases. 2002, Vol 34, pp S4-S16, issn 1058-4838, SUP1Article

Multidrug-resistant urinary tract isolates of Escherichia coli : Prevalence and patient demographics in the United States in 2000SAHM, Daniel F; THORNSBERRY, Clyde; MAYFIELD, David C et al.Antimicrobial agents and chemotherapy. 2001, Vol 45, Num 5, pp 1402-1406, issn 0066-4804Article

Prevalence of antimicrobial resistance among urinary tract pathogens isolated from female outpatients across the US in 1999KARLOWSKY, James A; JONES, Mark E; THORNSBERRY, Clyde et al.International journal of antimicrobial agents. 2001, Vol 18, Num 2, pp 121-127, issn 0924-8579Article

Contracting, prompting, and reinforcing substance use disorder continuing care : A randomized clinical trialLASH, Steven J; STEPHENS, Robert S; BURDEN, Jennifer L et al.Psychology of addictive behaviors. 2007, Vol 21, Num 3, pp 387-397, issn 0893-164X, 11 p.Article

Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoinKARLOWSKY, James A; THORNSBERRY, Clyde; JONES, Mark E et al.Clinical infectious diseases. 2003, Vol 36, Num 2, pp 183-187, issn 1058-4838, 5 p.Article

Trends in antimicrobial susceptibilities among Enterobacteriaceae isolated from hospitalized patients in the United States from 1998 to 2001KARLOWSKY, James A; JONES, Mark E; THORNSBERRY, Clyde et al.Antimicrobial agents and chemotherapy. 2003, Vol 47, Num 5, pp 1672-1680, issn 0066-4804, 9 p.Article

In vitro susceptibilities of Gram-negative bacteria isolated from hospitalized patients in four European countries, Canada, and the United States in 2000-2001 to expanded-spectrum cephalosporins and comparator antimicrobials: Implications for therapyWENZEL, Richard P; SAHM, Daniel F; THORNSBERRY, Clyde et al.Antimicrobial agents and chemotherapy. 2003, Vol 47, Num 10, pp 3089-3098, issn 0066-4804, 10 p.Article

The activity of levofloxacin and other antimicrobials against clinical isolates of Streptococcus pneumoniae collected worldwide during 1999-2002JONES, Mark E; BLOSSER-MIDDLETON, Renée S; THORNSBERRY, Clyde et al.Diagnostic microbiology and infectious disease. 2003, Vol 47, Num 4, pp 579-586, issn 0732-8893, 8 p.Article

In vitro activities of broad-spectrum cephalosporins against nonmeningeal isolates of Streptococcus pneumoniae: MIC interpretation using NCCLS M100-S12 recommendationsSAHM, Daniel F; THORNSBERRY, Clyde; MAYFIELD, David C et al.Journal of clinical microbiology (Print). 2002, Vol 40, Num 2, pp 669-674, issn 0095-1137Article